Covered recipient · General Payments record
ANTHONY J MARGHERITA
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$9,009.03
- Reported across 198 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $619.92 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $222.75 | 6 |
| GlaxoSmithKline, LLC. | $121.92 | 1 |
| Janssen Pharmaceuticals, Inc | $100.24 | 1 |
| Amgen Inc. | $46.69 | 2 |
| Medtronic, Inc. | $46.38 | 2 |
| DePuy Synthes Sales Inc. | $32.10 | 1 |
| GENZYME CORPORATION | $19.41 | 1 |
| UCB, Inc. | $16.31 | 1 |
| PFIZER INC. | $14.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $22.49 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111643762 | CMS |
| Amgen Inc. | $24.20 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111643764 | CMS |
| DePuy Synthes Sales Inc. | $32.10 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077865385 | CMS |
| GENZYME CORPORATION | $19.41 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139880233 | CMS |
| GlaxoSmithKline, LLC. | $121.92 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116653137 | CMS |
| Janssen Pharmaceuticals, Inc | $100.24 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078062222 | CMS |
| Lilly USA, LLC | $16.08 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051081 | CMS |
| Lilly USA, LLC | $23.36 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136047637 | CMS |
| Lilly USA, LLC | $21.13 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136047507 | CMS |
| Lilly USA, LLC | $121.17 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136047509 | CMS |
| Lilly USA, LLC | $17.34 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136044002 | CMS |
| Lilly USA, LLC | $23.67 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051083 | CMS |
| Medtronic, Inc. | $24.86 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119465683 | CMS |
| Medtronic, Inc. | $21.52 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119465685 | CMS |
| PFIZER INC. | $14.12 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131614921 | CMS |
| UCB, Inc. | $16.31 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143430255 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.